Searched for
MANKIND PHARMA ACQUISITION
Buy capital goods on dips, stay cautious on IT and consumption: Sudip BandyopadhyayMarket expert Sudip Bandyopadhyay outlines investment strategies across key sectors. He sees opportunities in State Bank of India and a gen...
Rupee at 95, crude at $120+: Why India's markets are flying blind into a stormMarket expert Sudip Bandyopadhyay warns Indian markets face significant risks. High oil prices and a potential monsoon deficit are major co...
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
Mankind Pharma shares in focus after Q3 net profit drops 16% YoY to Rs 385 croreMankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. ...
CCI clears Rs 13,630 cr Mankind Pharma acquisition of Bharat SerumsThe Competition Commission of India (CCI) has approved Mankind Pharma's ₹13,630-crore acquisition of Bharat Serums and Vaccines. This acqui...
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines dealThe Competition Commission of India has approved Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines. This acquisiti...
Mankind: How Meerut brothers built India's 4th largest pharma firmMankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly fu...
Market not much enthused by Mankind's BSV buyAfter initially cheering the deal, the stock market gave its thumbs-down to Mankind acquiring BSV at the premium valuations of eight times ...
Mankind Pharma taps Barclays and Deutsche Bank for Rs 13,630 cr acquisition of Bharat Serums & VaccinesMankind Pharma has appointed Barclays and Deutsche Bank to arrange financing for its Rs 13,630 crore acquisition of Bharat Serums & Vaccine...
Mankind to use debt, internal accruals to fund BSV buyoutMankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix o...
Mankind trumps EQT-ADIA to buy BSV for $1.67 bnThis is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...
Mankind Pharma scouts for M&A deals to boost local branded bizMankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensin...
Mankind joins race for Apax's surgical supplies company Healthium MedtechBidding for Healthium is likely to be competitive with several others such as KKR, Novo Nordisk, Hillhouse, Blackstone and EQT said to be a...
Mankind Pharma looking for selective acquisition opportunities: Rajiv JunejaMankind Pharma, a domestic-focused Indian pharmaceutical company is looking for selective acquisition opportunities that add value to its p...
Panacea Biotec hits 5% upper circuit after Mankind Pharma dealAs part of this arrangement, Mankind Pharma is retaining Panacea's sales and marketing team engaged in the particular business.
Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's LaboratoriesMankind Pharma said the market for Combihale is valued at Rs 900 crore growing at 14 per cent. The acquisition of the product is expected t...
CCI nod to Mankind Pharma acquisition by Cairnhill CIPEF and Cairnhill CGPE.The Competition Commission of India (CCI) has approved acquisition of 11% equity shares of Mankind Pharma by global private equity firm Cai...